Lung Cancer Screening with Low Dose Computed Tomography (LDCT)
https://www.cms.gov/medicare-coverage-database/view/ncd.aspx?NCDId=364
WEBFeb 10, 2022 · Indications and Limitations of Coverage. B. Nationally Covered Indications. Effective for claims with dates of service on or after February 10, 2022, CMS has determined that the evidence is sufficient to cover, under Medicare Part B, a lung cancer screening counseling and shared decision-making visit, and for appropriate beneficiaries, annual …
DA: 44 PA: 27 MOZ Rank: 25